前瞻性药物使用审查的评估结果：医疗补助示范项目
Evaluation results from prospective drug utilization review: Medicaid demonstrations.
作者信息
Kidder D, Bae J
机构信息
Abt Associates Inc., Cambridge, MA 02138-1168, USA.
出版信息
Health Care Financ Rev. 1999 Spring;20(3):107-18.
Abstract
In 1992 HCFA awarded two cooperative agreements for demonstrations of prospective drug utilization review (PDUR). Iowa tested an on-line prospective drug utilization review (OPDUR) system. Washington tested payments to pharmacists for providing non-dispensing "cognitive services" (CS). In this article the authors report on an evaluation of these demonstrations and on three assessments of retrospective drug utilization review (RDUR) interventions. The evaluation failed to detect effects of either State PDUR demonstration on the frequency of drug problems, utilization of prescription drugs and other health services, and clinical outcomes. However, the State RDUR interventions had immediate effects on prescribing physicians.
摘要
1992年，医疗保健财务管理局（HCFA）授予了两项合作协议，用于开展前瞻性药物使用审查（PDUR）示范项目。爱荷华州测试了一种在线前瞻性药物使用审查（OPDUR）系统。华盛顿州测试了向药剂师支付费用以提供非配药“认知服务”（CS）的情况。在本文中，作者报告了对这些示范项目的评估以及对回顾性药物使用审查（RDUR）干预措施的三项评估。评估未能发现任何一个州的PDUR示范项目对药物问题发生频率、处方药及其他医疗服务的使用情况以及临床结果产生影响。然而，州级RDUR干预措施对开处方的医生产生了即时影响。
相似文献
1
Evaluation results from prospective drug utilization review: Medicaid demonstrations.前瞻性药物使用审查的评估结果：医疗补助示范项目
Health Care Financ Rev. 1999 Spring;20(3):107-18.
2
Drug use and prescribing problems in four state Medicaid programs.四个州医疗补助计划中的药物使用及处方问题。
Health Care Financ Rev. 1999 Spring;20(3):63-78.
3
Medicaid program; cost sharing demonstrations--HCFA. General notice.医疗补助计划；成本分摊示范——医疗保健财务管理局。一般通知。
Fed Regist. 1982 May 28;47(104):23572-6.
4
Trends in Medicaid prescription drug utilization and payments, 1990-97.1990 - 1997年医疗补助计划处方药使用及支付趋势
Health Care Financ Rev. 1999 Spring;20(3):79-105.
5
Perils of pioneering: monitoring Medicaid managed care.开拓的风险：监测医疗补助管理式医疗
Health Care Financ Rev. 2000 Winter;22(2):61-83.
6
Differences in the cost of antidepressants across state Medicaid programs.各州医疗补助计划中抗抑郁药物成本的差异。
J Ment Health Policy Econ. 2008 Mar;11(1):33-47.
7
Payment, administration, and financing of the Medicaid program.医疗补助计划的支付、管理与融资。
Health Care Financ Rev Annu Suppl. 1992:285-301.
8
Cost analyses of the Arizona Health Care Cost Containment System: lessons from an eleven-year evaluation.亚利桑那州医疗成本控制系统的成本分析：来自十一年评估的经验教训。
Adv Health Econ Health Serv Res. 1995;15:79-97.
9
Capitated payment approaches for Medicaid-financed long-term care services.医疗补助计划资助的长期护理服务的按人头付费方式。
Health Care Financ Rev. 1999 Fall;21(1):51-64.
10
Maintaining a mission. Medicaid plans focus on pharmaceutical care.
Healthplan. 2002 Jul-Aug;43(4):54-6.
引用本文的文献
1
Pharmacists' Perceptions on Safety Alerts of the Drug Utilization Review (DUR) in Electronic Health Records in a Tertiary Healthcare Hospital.三级医疗医院药剂师对电子健康记录中药物利用审查（DUR）安全警报的认知
Pharmacy (Basel). 2023 Jul 20;11(4):119. doi: 10.3390/pharmacy11040119.
2
Comparing the Medicaid Prospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies in 2015 and 2016.比较2015年和2016年各州机构使用的医疗补助预期药物利用审查计划成本节约方法。
Am Health Drug Benefits. 2019 Feb;12(1):7-12.
3
Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies.比较各州机构使用的医疗补助回顾性药物利用审查计划成本节约方法。
Am Health Drug Benefits. 2017 Dec;10(9):477-482.
4
The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population.在门诊护理人群中将回顾性用药分析添加到计算机医嘱录入系统中的效用。
J Am Med Inform Assoc. 2007 Jul-Aug;14(4):424-31. doi: 10.1197/jamia.M2313. Epub 2007 Apr 25.
5
From physician to consumer: the effectiveness of strategies to manage health care utilization.从医生到消费者：管理医疗保健利用的策略效果
Med Care Res Rev. 2002 Dec;59(4):455-81. doi: 10.1177/107755802237811.
本文引用的文献
1
Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.将医生的处方转向首选的组胺-2受体拮抗剂。多因素干预在混合型健康维护组织中的效果。
Med Care. 1998 Mar;36(3):321-32. doi: 10.1097/00005650-199803000-00009.
2
A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.一项旨在改变处方行为的对照信函干预措施：双目标方法的结果
Health Serv Res. 1997 Oct;32(4):471-89.
3
Achieving guidelines for the treatment of depression in primary care: is physician education enough?在初级保健中实现抑郁症治疗指南：医生教育是否足够？
Med Care. 1997 Aug;35(8):831-42. doi: 10.1097/00005650-199708000-00008.
4
Retrospective drug utilization review and the behavior of Medicaid prescribers: an empirical marginal analysis.回顾性药物利用审查与医疗补助开方者的行为：实证边际分析
Clin Ther. 1995 Nov-Dec;17(6):1174-87. doi: 10.1016/0149-2918(95)80096-4.
5
Documenting the value of pharmacist interventions.记录药剂师干预措施的价值。
Am Pharm. 1994 May;NS34(5):50-4. doi: 10.1016/s0160-3450(15)30430-x.
6
Evaluation of a DUR intervention: a case study of histamine antagonists.药物利用审查干预措施的评估：组胺拮抗剂的案例研究
Inquiry. 1994 Spring;31(1):89-101.
7
Changing physician performance. A systematic review of the effect of continuing medical education strategies.改变医生的行为表现。对继续医学教育策略效果的系统评价。
JAMA. 1995 Sep 6;274(9):700-5. doi: 10.1001/jama.274.9.700.
8
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".通过教育推广改善药物治疗决策。一项基于学术的“详细介绍”随机对照试验。
N Engl J Med. 1983 Jun 16;308(24):1457-63. doi: 10.1056/NEJM198306163082406.
9
Documenting prescribing errors and pharmacist interventions in community pharmacy practice.记录社区药房实践中的处方错误及药剂师干预措施。
Am Pharm. 1988 Sep;NS28(9):30-7. doi: 10.1016/s0160-3450(16)33451-1.
10
Psychotropic drug use and the risk of hip fracture.精神药物的使用与髋部骨折风险
N Engl J Med. 1987 Feb 12;316(7):363-9. doi: 10.1056/NEJM198702123160702.
Zotero 插件